Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
NCT03371082 is a phase 3 interventional trial sponsored by Gan and Lee Pharmaceuticals, USA. As of 21 Nov 2026, it is completed. It studies Gan & Lee Insulin Glargine Injection and Lantus® in Diabetes Mellitus, Type 1. The registry lists an enrollment of 576 participants at 85 sites in 6 countries. The registry lists a start date of 31 Oct 2017 and a primary completion date of 19 Aug 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03371082 |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | Gan and Lee Pharmaceuticals, USA |
| Enrollment | 576 |
| Registered sites | 85 |
| Countries | 6 |
| Conditions | Diabetes Mellitus, Type 1 |
| Drugs | Gan & Lee Insulin Glargine Injection and Lantus® |
| Start | 31 Oct 2017 |
| Primary completion | 19 Aug 2019 |
| Study completion | 19 Aug 2019 |
| Last update posted | 14 May 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Elena A. Christofides, MD,FACE
Endocrinology Research Associates, Inc.
Principal Investigator - Jia Lu, MD, PhD
Gan & Lee Pharmaceuticals, USA
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
85 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham
- Valley Research
Fresno
- the Rose Salter Medical Research Foundation
Newport Beach
- California Medical Research Association
Northridge
- Metabolic Institute of America
Tarzana
- Cmr of Greater New Haven, Llc
Hamden
- Meridien Research
Bradenton
- the Center for Diabetes and Endocrine Care
Fort Lauderdale
- Homestead Associates in Research
Homestead
- Central Florida Endocrine and Diabetes Consultants - Maitland
Maitland
- Biotech Pharmaceutical Group, Llc
Miami
- Miami Dade Medical Research Institute, Llc
Miami
- New Horizon Research Center
Miami
- Suncoast Clinical Research, Inc.
New Port Richey
- Peninsula Research
Ormond Beach
- Oviedo Medical Research, Llc
Oviedo
- Metabolic Research Institute, Inc.
West Palm Beach
- River Birch Research Alliance, Llc
Blue Ridge
- Iresearch Atlanta
Decatur
- Sestron Clinical Research
Marietta
- Endocrine Research Solutions, Inc.
Roswell
- East-West Medical Research Institute
Honolulu
- Advanced Clinical Research - Idaho
Meridian
- Cedar Crosse Research Center
Chicago
- John H. Stroger Jr. Hospital of Cook County
Chicago
- Midwest Crc
Crystal Lake
- Iowa Diabetes and Endocrinology Research Center
West Des Moines
- Kentucky Diabetes Endocrinology Center
Lexington
- Palm Research Center, Inc.
Las Vegas
- Physicians East - Greenville
Greenville
- Lillestol Research Llc
Fargo
- Aventiv Research, Inc.
Columbus
- Endocrinology Reserach Associates, Inc.
Columbus
- Primed Clinical Research
Dayton
- Clinsearch - Clinical Research Specialists
Chattanooga
- University Diabetes & Endocrine Consultants
Chattanooga
- New Phase Research & Development
Knoxville
- Texas Diabetes & Endocrinology - Central Austin
Austin
- Texas Diabetes & Endocrinology - South Austin
Austin
- Research Institute of Dallas
Dallas
- Texas Diabetes & Endocrinology - Round Rock
Round Rock
- Clinical Trials of Texas
San Antonio
- Northeast Clinical Research of San Antonio
Schertz
- Radiant Research
Murray
- Advanced Research Institute
Ogden
- Wasatch Clinical Research, Llc
Salt Lake City
- Burke Internal Medicine & Research
Burke
- Stonesifer Clinical Research
Federal Way
- Rainier Clinical Research Center, Inc.
Renton
- Multicare Health System Institute for Research & Innovation
Tacoma
- Hospital Universitari de Girona Doctor Josep Trueta
Girona, Gerona
- Complejo Hospitalario Universitario de Ferrol
Ferrol, LA Coruna
- Centro de Especialidades San Jose Obrero. Hospital Universitario Virgen de la Victoria
Málaga, Malaga
- Complejo Hospitalario Universitario la Coruña
A Coruña
- Hospital Universitario Ramón Y Cajal
Madrid
- Hospital Universitario Nuestra Señora de Valme
Seville
- Nuevas Tecnologías En Diabetes Y Endocrinología
Seville
- Consorci Hospital General Universitari de València
Valencia
- Krajská Zdravotní, A.S., Masarykova Nemocnice V Ústí Nad Labem
Ústí nad Labem, Severoceský KRAJ
- Diabetologie České Budějovice S.R.O
České Budějovice, South Bohemian Region
- Diahaza S.R.O.
Holešov
- Stefamed
Hradec Králové
- Diabetologie Mudr. Tomáš Edelsberger
Krnov
- Preventamed
Olomouc
- Genom S.R.O
Ostrava
- Cru Hungary Egészségügyi És Szolgáltató Kft.
Miskolc, Borsod-Abauj Zemplen county
- Lausmed Egeszsegugyi Es Szolgaltato Kft.
Baja, Bács-Kiskun county
- Markhot Ferenc Oktatókórház És Rendelointézet
Eger, Heves County
- Zala County Hospital
Zalaegerszeg, Zala County
- Betegapolo-Irgalmasrend Budai Irgalmasrendi Kórház, Diabetológiai Ambulancia
Budapest
- Semmelweis Egyetem Ii. Sz. Belgyógyászati Klinika
Budapest
- Synexus Magyarország
Budapest
- Praktyka Lekarska Ewa Krzyzagórska
Poznan, Greater Poland Voivodeship
- Nzoz Medyczne Centrum Diabetologiczno-Endokrynologiczno-Metaboliczne "diab-Endo-Met"
Krakow, Lesser Poland Voivodeship
- Pratia Mcm Kraków
Krakow, Lesser Poland Voivodeship
- Ko-Med Centra Kliniczne Lublin - Królewska
Lublin, Lublin Voivodeship
- Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych I Administracji W Warszawie
Warsaw, Masovian Voivodeship
- Centrum Badań Klinicznych Pi-House
Gdansk, Pomeranian Voivodeship
- Niepubliczny Zaklad Opieki Zdrowotnej Gdanska Poradnia Cukrzycowa
Gdansk, Pomeranian Voivodeship
- Studienzentrum Aschaffenburg
Aschaffenburg, Bavaria
- Diabetes-Falkensee.de
Falkensee, Brandenburg
- Gemeinschaftspraxis Diabeteszentrum Dortmund
Dortmund, North Rhine-Westphalia
- Diabetes Schwerpunktpraxis, Gemeinschaftspraxis Alain Barakat Und Helene Willems
Duisburg, North Rhine-Westphalia
- Diabetologische Schwerpunktpraxis Pirna
Pirna, Saxony
- Red-Institut Gmbh
Oldenburg in Holstein, Schleswig-Holstein
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT03371082
Each answer restates registry values shown on this page.
What is NCT03371082?
NCT03371082 is a phase 3 interventional trial sponsored by Gan and Lee Pharmaceuticals, USA. It studies Gan & Lee Insulin Glargine Injection and Lantus® in Diabetes Mellitus, Type 1.
Who leads NCT03371082?
The registry names Elena A. Christofides, MD,FACE (principal investigator, Endocrinology Research Associates, Inc.) and Jia Lu, MD, PhD (study director, Gan & Lee Pharmaceuticals, USA) as overall officials.
Where does NCT03371082 run?
The registry lists 85 sites in 6 countries. Most sites are in these countries: United States (50), Spain (8) and Czechia (7).
Which drugs does NCT03371082 study?
The registered drug and biological interventions are Gan & Lee Insulin Glargine Injection and Lantus®.
When did NCT03371082 end?
The registry lists a primary completion date of 19 Aug 2019 and a study completion date of 19 Aug 2019. The sponsor last updated the record on 14 May 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.